id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-0307-0002,FDA,FDA-2012-D-0307,"Draft Guidance for Industry: Revised Preventive Measures to Reduce Possible Risk of Transmission of Creutzfeldt-Jakob Disease, etc.",Other,Guidance,2012-06-12T04:00:00Z,2012,6,2012-06-12T04:00:00Z,,2012-06-12T16:37:12Z,,0,0,09000064810413e8
FDA-2012-D-0307-0001,FDA,FDA-2012-D-0307,"Draft Guidance for Industry: Revised Preventive Measures to Reduce Possible Risk of Transmission of Creutzfeldt-Jakob Disease, etc.; Amendment",Notice,Notice of Availability,2012-06-11T04:00:00Z,2012,6,2012-06-11T04:00:00Z,2012-09-11T03:59:59Z,2012-09-20T02:01:13Z,2012-14034,0,0,0900006481040b4c